Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus × Exercise × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 33 Motor Activity 23 Breast Neoplasms 5 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Neoplasms 3 Fatigue 3 Carcinoma, Renal Cell 3 Ovarian Neoplasms 2 Kidney Neoplasms 2 Thyroid Neoplasms 1 Testicular Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Prostatectomy 1 Obesity 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Metabolic Syndrome 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Insulin Resistance 1 Hypoxia 1 Endometrial Neoplasms 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Carcinoma, Transitional Cell 1

Interventions

tocilizumab 1 Tirzepatide 1 Testosterone 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Pioglitazone 1 Palliative Care 1 Nutrition Assessment 1 Lysine Acetyltransferase 5 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Exercise 1 Disulfides 1 Diet, Carbohydrate-Restricted 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02716623 2019-07-15

DEAL

University of Kansas Medical Center

Phase NA Completed

Urinary Bladder Neoplasms, Diabetes Mellitus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡